Return
Crizotinib
DOI:10.1038/nrd3600.png)
Abstract
En
Keywords:
CELL LUNG-CANCER
ANAPLASTIC LYMPHOMA KINASE
INHIBITORS
GENE
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
101.8
Papers:
5.1K
Citations:
5.3W
Organization
Cited Papers
Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors
CANCER RESEARCH
IF16.6
An orally available small-molecule inhibitor of c-met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms
CANCER RESEARCH
IF16.6
no more

